Latest filing published 17 Aug 2026 for Corbus Pharmaceuticals Holdings, Inc.. Read the official filing
No signal scores available.
Filings by Leonardo Viana Nicacio span 2 companies, the busiest being Protara Therapeutics, Inc. and Corbus Pharmaceuticals Holdings, Inc. The record holds 3 filings, for trades running from 15 April 2025 to 16 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 17 August 2026 came the latest disclosure, a share grant in Corbus Pharmaceuticals Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations